Concepedia

D. Lawson

DL

Statistics

Publications

2

Citations

64

H-Index

2

Active since

2009

Affiliations

Winship Cancer Institute(Current)

D. Lawson is an author at Winship Cancer Institute specializing in immunodeficiencies, oncology, and tumor immunity.

Top concepts

Publications per year

2009–2009

2

Publications

2

A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma

Douglas J. Schwartzentruber, D. Lawson, James Richards et al. · Journal of Clinical Oncology · 2009 · 50 citations

, , +24

A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma

Douglas J. Schwartzentruber, D. Lawson, James Richards et al. · Journal of Clinical Oncology · 2009 · 14 citations

, , +24

1–2 of 2